UCB SA (UCBJY)
OTCMKTS · Delayed Price · Currency is USD
168.73
+1.19 (0.71%)
Feb 18, 2026, 11:07 AM EST
UCB SA Market Cap
UCB SA has a market cap or net worth of $64.07 billion as of February 18, 2026. Its market cap has increased by 71.32% in one year.
Market Cap
64.07B
Enterprise Value
65.57B
Revenue
8.04B
Ranking
n/a
PE Ratio
40.96
Stock Price
$168.73
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 1.20B to 64.07B, an increase of 5,236.45%. That is a compound annual growth rate of 13.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 64.07B | 20.38% |
| Dec 31, 2025 | 53.23B | 40.99% |
| Dec 31, 2024 | 37.75B | 128.16% |
| Dec 29, 2023 | 16.55B | 10.80% |
| Dec 30, 2022 | 14.93B | -30.70% |
| Dec 31, 2021 | 21.55B | 10.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 383.25M |
| CytoDyn | 308.63M |
| Silence Therapeutics | 210.19M |
| HST Global | 139.70M |
| Vaxart | 135.83M |
| BioStem Technologies | 97.44M |
| Nuo Therapeutics | 77.26M |
| Vicapsys Life Sciences | 48.56M |